The pharmaceutical excipient SNAC market is projected to grow from USD 15.2 million in 2025 to USD 30.7 million by 2035, at a CAGR of 7.3%. Purity 99% will dominate with a 60.0% market share, while pharmaceuticals will lead the application segment with a 70.0% share.